Keurig Dr Pepper’s (NASDAQ:KDP) Q1: Beats On Revenue
April 24, 2025
Beverage company Keurig Dr Pepper (NASDAQ:KDP) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 4.8% year on year to $3.64 billion. Its non-GAAP profit of $0.42 per share was 9.8% above analysts’ consensus estimates.
Born out of a 2018 merger between Keurig Green Mountain and Dr Pepper Snapple, Keurig Dr Pepper (NASDAQ:KDP) is a consumer staples powerhouse boasting a portfolio of beverages including sodas, coffees, and juices.
Beverages, Alcohol, and Tobacco
These companies' performance is influenced by brand strength, marketing strategies, and shifts in consumer preferences. Changing consumption patterns are particularly relevant and can be seen in the rise of cannabis, craft beer, and vaping or the steady decline of soda and cigarettes. Companies that spend on innovation to meet consumers where they are with regards to trends can reap huge demand benefits while those who ignore trends can see stagnant volumes. Finally, with the advent of the social media, the cost of starting a brand from scratch is much lower, meaning that new entrants can chip away at the market shares of established players.
Sales Growth
Examining a company’s long-term performance can provide clues about its quality. Any business can have short-term success, but a top-tier one grows for years.
With $15.52 billion in revenue over the past 12 months, Keurig Dr Pepper is one of the larger consumer staples companies and benefits from a well-known brand that influences purchasing decisions. However, its scale is a double-edged sword because it’s harder to find incremental growth when your existing brands have penetrated most of the market. For Keurig Dr Pepper to boost its sales, it likely needs to adjust its prices, launch new offerings, or lean into foreign markets.
As you can see below, Keurig Dr Pepper grew its sales at a mediocre 6.5% compounded annual growth rate over the last three years, but to its credit, consumers bought more of its products.
This quarter, Keurig Dr Pepper reported modest year-on-year revenue growth of 4.8% but beat Wall Street’s estimates by 1.9%.
Looking ahead, sell-side analysts expect revenue to grow 4.9% over the next 12 months, a slight deceleration versus the last three years. This projection is underwhelming and indicates its products will face some demand challenges.
Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on
a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next
.
Volume Growth
Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there’s a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive.
Keurig Dr Pepper’s average quarterly volume growth was a healthy 1.5% over the last two years. This is pleasing because it shows consumers are purchasing more of its products.
In Keurig Dr Pepper’s Q1 2025, sales volumes jumped 8% year on year. This result was an acceleration from its historical levels, certainly a positive signal.
Key Takeaways from Keurig Dr Pepper’s Q1 Results
It was encouraging to see Keurig Dr Pepper beat analysts’ EPS and EBITDA expectations this quarter. We were also happy its revenue outperformed Wall Street’s estimates. On the other hand, its gross margin slightly missed. Overall, this quarter had some key positives. The stock traded up 2.3% to $35.94 immediately following the results.
Keurig Dr Pepper put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings.
We cover that in our actionable full research report which you can read here, it’s free
.
